29 related articles for article (PubMed ID: 31527330)
1. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.
Jia H; Li Y; Zhao T; Li X; Hu J; Yin D; Guo B; Kopecko DJ; Zhao X; Zhang L; Xu DQ
Cancer Immunol Immunother; 2012 Nov; 61(11):1977-87. PubMed ID: 22527247
[TBL] [Abstract][Full Text] [Related]
2. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
Zhang J; Yang J; Roy SK; Tininini S; Hu J; Bromberg JF; Poli V; Stark GR; Kalvakolanu DV
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9342-7. PubMed ID: 12867595
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization.
Chen W; Liu Q; Fu B; Liu K; Jiang W
Life Sci; 2018 Sep; 208():232-238. PubMed ID: 30005830
[TBL] [Abstract][Full Text] [Related]
4. Retraction: Identification and characterization of GRIM-1, a cell-death-associated gene product.
Hofmann ER; Nallar SC; Lin L; D'Cunha J; Lindner DJ; Weihua X; Kalvakolanu DV
J Cell Sci; 2021 Nov; 134(22):. PubMed ID: 34817589
[No Abstract] [Full Text] [Related]
5. A Pegylated Liposome Loaded with Raddeanin A for Prostate Cancer Therapy.
He K; Wang T; Chen J; Huang X; Wang Z; Yang Z; Wang K; Zhao W; Jiang J; Zhao L
Int J Nanomedicine; 2023; 18():4007-4021. PubMed ID: 37496689
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis.
Huang J; Yang Y; Zhao F; Zhang Z; Deng J; Lu W; Jiang X
Cancer Cell Int; 2023 Apr; 23(1):82. PubMed ID: 37118800
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy.
Chen J; Zhao S; Tan W; Wang T; Wu S; Wang C; Jiang Y; Zhou T; Zhang Z; Zhao L
Sci Rep; 2021 Oct; 11(1):20083. PubMed ID: 34635698
[TBL] [Abstract][Full Text] [Related]
8. Atrazine Promoted Epithelial Ovarian Cancer Cells Proliferation and Metastasis by Inducing Low Dose Reactive Oxygen Species (ROS).
Chen J; Liu J; Wu S; Liu W; Xia Y; Zhao J; Yang Y; Wang Y; Peng Y; Zhao S
Iran J Biotechnol; 2021 Apr; 19(2):e2623. PubMed ID: 34435054
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the association between KIN17 expression and the clinical features/prognosis of epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells.
Chen J; Xia Y; Peng Y; Wu S; Liu W; Zhang H; Wang T; Yang Z; Zhao S; Zhao L
Oncol Lett; 2021 Jun; 21(6):475. PubMed ID: 33907585
[TBL] [Abstract][Full Text] [Related]
10. GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.
Nallar SC; Kalvakolanu DV
Cytokine Growth Factor Rev; 2017 Feb; 33():1-18. PubMed ID: 27659873
[TBL] [Abstract][Full Text] [Related]
11. GRIM-19 function in cancer development.
Moreira S; Correia M; Soares P; Máximo V
Mitochondrion; 2011 Sep; 11(5):693-9. PubMed ID: 21664299
[TBL] [Abstract][Full Text] [Related]
12. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth.
Kong D; Zhao L; Du Y; He P; Zou Y; Yang L; Sun L; Wang H; Xu D; Meng X; Sun X
Int J Clin Exp Pathol; 2014; 7(11):7497-507. PubMed ID: 25550785
[TBL] [Abstract][Full Text] [Related]
14. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
15.
Cao F; Zhang Q; Chen W; Zheng F; Ran Q; He Y; Gao Y; Yao S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074558
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
